Liquidia Technologies Announces $22.4 Million Private Placement
December 24, 2019 08:30 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 24, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company focused on the development and...
Liquidia Technologies Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 13, 2019 07:00 ET
|
Liquidia Technologies, Inc.
Completed Registrational Studies of LIQ861 to Include in New Drug Application (NDA)Targeting Submission of NDA for LIQ861 in 1Q 2020Management to Host Webcast and Conference Call Today at 8:00 a.m. ET...
Liquidia to Report Third Quarter 2019 Financial Results and Provide Corporate Update on November 13, 2019
November 06, 2019 08:00 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, today...
Liquidia Technologies Appoints Industry Veteran Katie Rielly-Gauvin to Board of Directors
November 01, 2019 08:00 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, today...
Liquidia to Present at Cantor 2019 Global Healthcare Conference
September 25, 2019 16:05 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, announced...
Liquidia Technologies Appoints Industry Veteran Dr. Joanna Horobin to Board of Directors
September 12, 2019 16:05 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, today...
Liquidia to Present at H.C. Wainwright Healthcare Conference
September 03, 2019 07:00 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, announced...
Liquidia to Present at Wedbush PacGrow Healthcare Conference
August 08, 2019 16:05 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, announced...
Liquidia Technologies Reports Second Quarter 2019 Financial Results and Provides Corporate Update
August 08, 2019 07:00 ET
|
Liquidia Technologies, Inc.
On Track for Planned New Drug Application (NDA) Submission for LIQ861 in Late 2019 Continued Pipeline Progress Leveraging Proprietary PRINT® Technology Management to Host Webcast and Conference Call...
Liquidia to Report Second Quarter 2019 Financial Results and Provide Corporate Update on August 8, 2019
August 02, 2019 09:00 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company focused on the development and...